LUCD

Lucid Diagnostics
$0.90
−$0.00 (−0.55%)Jul 27, 2026
1.8PoorMoatMint rating

MoatMint rates Lucid Diagnostics (LUCD) 1.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.5 out of 10.

Key metrics

The numbers that frame LUCD today
Market cap
$183.37M
P/E (TTM)
-4.1
EV / FCF
-3.9
Gross margin
-31.4%
EV / Sales
35.5
ROIC
-1,216.2%
Div yield
0%
Debt / equity
6.7
52wk Low
$0.90
52wk High
$1.63

LUCD stock rating

How LUCD scores on quality, value, growth, momentum and financial health
1.8out of 10
Low overallFair business, expensive priceTop 82% of ~5,000 US stocks
QualityPoor0.5/10
GrowthGreat9.8/10
MomentumFair3.7/10
ValuePoor1.3/10
Financial HealthFair2.1/10

Growth

Revenue and earnings trend for LUCD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about LUCD
Is Lucid Diagnostics a good buy?
No. Lucid Diagnostics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Lucid Diagnostics is selling at a very high price.
What is the market capitalization of LUCD?
Lucid Diagnostics's market capitalization is $183.37M.
What is the P/E ratio for LUCD stock?
Lucid Diagnostics's current P/E ratio is -4.1.
What is the 52-week high for LUCD stock?
The 52-week high for Lucid Diagnostics is $1.63. The current close of $0.90 is 44.6% below that high.
What is the 52-week low for LUCD stock?
The 52-week low for Lucid Diagnostics is $0.90. The current close of $0.90 is 0.3% above that low.
Does LUCD stock pay dividends?
Lucid Diagnostics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LUCD?
Lucid Diagnostics's Debt / Equity ratio is 6.7.